NL172401C - METHOD FOR PREPARING OR MANUFACTURING A PHARMACEUTICAL PREPARATION CONTAINING A HYDROGENATED MOTHER-CHALK CALOID. - Google Patents

METHOD FOR PREPARING OR MANUFACTURING A PHARMACEUTICAL PREPARATION CONTAINING A HYDROGENATED MOTHER-CHALK CALOID.

Info

Publication number
NL172401C
NL172401C NLAANVRAGE7613316,A NL7613316A NL172401C NL 172401 C NL172401 C NL 172401C NL 7613316 A NL7613316 A NL 7613316A NL 172401 C NL172401 C NL 172401C
Authority
NL
Netherlands
Prior art keywords
caloid
chalk
mother
hydrogenated
preparing
Prior art date
Application number
NLAANVRAGE7613316,A
Other languages
Dutch (nl)
Other versions
NL172401B (en
NL7613316A (en
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2554533A external-priority patent/DE2554533C3/en
Priority claimed from DE19762625403 external-priority patent/DE2625403A1/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NL7613316A publication Critical patent/NL7613316A/en
Publication of NL172401B publication Critical patent/NL172401B/en
Application granted granted Critical
Publication of NL172401C publication Critical patent/NL172401C/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Electronic Switches (AREA)
NLAANVRAGE7613316,A 1975-12-04 1976-11-30 METHOD FOR PREPARING OR MANUFACTURING A PHARMACEUTICAL PREPARATION CONTAINING A HYDROGENATED MOTHER-CHALK CALOID. NL172401C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2554533A DE2554533C3 (en) 1975-12-04 1975-12-04 Use of dihydroergotamine and heparin
DE19762625403 DE2625403A1 (en) 1976-06-05 1976-06-05 Antithrombotic association of medicaments - contains heparin and an ergoline-(8)-carboxylic acid peptidic amide esp. dihydroergotamine opt. with polyvinyl pyrrolidone

Publications (3)

Publication Number Publication Date
NL7613316A NL7613316A (en) 1977-06-07
NL172401B NL172401B (en) 1983-04-05
NL172401C true NL172401C (en) 1983-09-01

Family

ID=25769698

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7613316,A NL172401C (en) 1975-12-04 1976-11-30 METHOD FOR PREPARING OR MANUFACTURING A PHARMACEUTICAL PREPARATION CONTAINING A HYDROGENATED MOTHER-CHALK CALOID.

Country Status (17)

Country Link
JP (1) JPS5270031A (en)
AU (1) AU512782B2 (en)
CS (1) CS216164B2 (en)
ES (1) ES453869A1 (en)
FR (1) FR2333513A1 (en)
GB (1) GB1557331A (en)
HK (1) HK3083A (en)
IE (1) IE44359B1 (en)
IL (1) IL51043A (en)
IT (1) IT7827782A0 (en)
MY (1) MY8400064A (en)
NL (1) NL172401C (en)
NZ (1) NZ182790A (en)
PH (1) PH12759A (en)
PT (1) PT65919B (en)
SE (1) SE441142B (en)
SG (1) SG63482G (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2809618A1 (en) * 1978-03-06 1979-09-20 Sandoz Ag NEW THERAPEUTIC PREPARATION AND METHOD FOR THE PRODUCTION THEREOF
CH656533A5 (en) * 1982-12-10 1986-07-15 Sandoz Ag THERAPEUTIC PREPARATION CONTAINING HYDRATED ERGOTAL CALOIDS AND LOW MOLECULAR HEPARINE.

Also Published As

Publication number Publication date
CS216164B2 (en) 1982-10-29
IE44359L (en) 1977-06-04
HK3083A (en) 1983-01-20
GB1557331A (en) 1979-12-05
ES453869A1 (en) 1978-01-16
NL172401B (en) 1983-04-05
MY8400064A (en) 1984-12-31
NL7613316A (en) 1977-06-07
JPS5270031A (en) 1977-06-10
AU2024976A (en) 1978-06-08
AU512782B2 (en) 1980-10-30
PT65919A (en) 1977-01-01
SE7613252L (en) 1977-06-05
FR2333513B1 (en) 1980-03-28
NZ182790A (en) 1979-03-16
PT65919B (en) 1978-07-05
SE441142B (en) 1985-09-16
SG63482G (en) 1983-09-09
FR2333513A1 (en) 1977-07-01
IT7827782A0 (en) 1978-09-18
IE44359B1 (en) 1981-11-04
PH12759A (en) 1979-08-09
IL51043A0 (en) 1977-02-28
IL51043A (en) 1980-02-29

Similar Documents

Publication Publication Date Title
NL187102C (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION CONTAINING A 2-PHENYLIMIDAZOLIDINONE, FORMED PREPARED OBTAINED BY THIS PROCESS AND PROCESS FOR THE PREPARATION OF IMIDAZOLIDINONES.
NL187892C (en) METHOD FOR PREPARING OR MANUFACTURING A PHARMACEUTICAL PREPARATION CONTAINING A DIHYDROGER PHOTOXIN, AND APPARATUS FOR NOSE ADMINISTRATION OF A PHARMACEUTICAL PREPARATION
NL178125B (en) METHOD FOR PREPARING A FLAVOR SUBSTANCE
NL7507441A (en) METHOD OF PREPARING A MEDICINAL PRODUCT, SUCH MEDICINAL PRODUCT AND PROCEDURE FOR PREPARING SUITABLE MEDICINAL COMPOUNDS.
NL7604016A (en) PROCEDURE FOR PREPARING PROSTAGLANDIN DERIVATIVES AND PROCEDURE FOR PREPARING A MEDICINAL PRODUCT CONTAINING PROSTAGLANDIN ACTION.
NL184893C (en) 1-PHENYL-2-ALKYLAMINOETHANOLS AND METHOD FOR PREPARING OR MANUFACTURING A PHARMACEUTICAL PREPARATION, IN PARTICULAR SOURCE-DILATOR ACTION CONTAINING SUCH A COMPOUND
NL167683B (en) METHOD FOR PREPARING OR MANUFACTURING A PHARMACEUTICAL PREPARATION AND METHOD FOR PREPARING N-ACYLPHENYLALANYLAMIDES
NL7607902A (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION.
NL184558C (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION CONTAINING A MOTHERNESS CALCALIDE; PHARMACEUTICAL OBJECT.
NL186676C (en) METHOD FOR PREPARING OR MANUFACTURING AN AESCIN-CONTAINING PHARMACEUTICAL PREPARATION; FORMED PHARMACEUTICAL PREPARATION.
NL7607011A (en) METHOD FOR PREPARING BICYCLOHEPEN COMPOUNDS, METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION USING THEREOF AND AN SUCH PREPARATION.
NL7613206A (en) METHOD OF PREPARING A MEDICINAL PRODUCT.
NL7601114A (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION.
NL172953C (en) METHOD FOR PREPARING AND/OR MANUFACTURING A PHARMACEUTICAL PREPARATION CONTAINING A 4-ŸOMEGA-(CUMARIN-7-YLOXY)-ALKYLŸ-PIPERAZINE DERIVATIVE AND METHOD FOR PREPARING SUCH A THERAPEUTICAL APPLICATION.
NL7605322A (en) PROCESS FOR PREPARING A THERAPEUTIC PREPARATION.
NL7604777A (en) PROCESS FOR PREPARING A TISSUE-FRESHING PREPARATION.
NL7706888A (en) METHOD OF PREPARING A PHARMACEUTICAL PREPARATION.
NL182283C (en) METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION
NL7707849A (en) METHOD OF PREPARING A PHARMACEUTICAL PREPARATION.
NL7800016A (en) METHOD OF PREPARING A PHARMACEUTICAL PREPARATION.
NL176362C (en) PROCESS FOR PREPARING A 4- (2-ACYLOXY-3-AMINOPROPOXY) INDOLE AND PHARMACEUTICAL PREPARATION CONTAINING THIS COMPOUND
NL7706619A (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION.
NL7706887A (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION CONTAINING A DERIVATIVE OF PIPERAZINE AND SALTS BJARVAN.
NL7708807A (en) METHOD OF PREPARING A PHARMACEUTICAL PREPARATION.
NL7601423A (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION.

Legal Events

Date Code Title Description
V1 Lapsed because of non-payment of the annual fee